Intrahepatic cholangiocarcinoma and gallbladder cancer: distinguishing molecular profiles to guide potential therapy
Potkonjak M, Miura J, Turaga K, Johnston F, Tsai S, Christians K, Gamblin T. Intrahepatic cholangiocarcinoma and gallbladder cancer: distinguishing molecular profiles to guide potential therapy. Hepato Pancreato Biliary 2015, 17: 1119-1123. PMID: 26374242, PMCID: PMC4644364, DOI: 10.1111/hpb.12504.Peer-Reviewed Original ResearchMeSH KeywordsAdenocarcinomaAntineoplastic Combined Chemotherapy ProtocolsBile Duct NeoplasmsBiomarkers, TumorCholangiocarcinomaDiagnosis, DifferentialFemaleGallbladder NeoplasmsHumansImmunohistochemistryMaleMiddle AgedMolecular Diagnostic TechniquesMolecular Targeted TherapyPatient SelectionPredictive Value of TestsRetrospective StudiesConceptsGallbladder adenocarcinomaIntrahepatic cholangiocarcinomaMolecular profilingGC patientsCaris Life SciencesLow thymidylate synthaseBiomarker expression patternsThymidylate synthasePotential therapeutic implicationsFrequency of GCChemotherapy regimensICC tumorsPlatinum agentsGallbladder cancerTumor originPotential increased benefitsPathological specimensLevels of TSImmunohistochemical analysisSubgroup analysisTreatment strategiesPotential therapiesTherapeutic implicationsResponse rateTumor
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply